Difficulty: Medium
Average Score: 64%
Practice
What is the common mechanism of action of all the Class 1 Antiarrhythmic drugs?
Correct answer
C
Rationale
Class I antiarrhythmic drugs primarily exert their therapeutic effects by blocking sodium channels.
Class I antiarrhythmic drugs, encompassing subclasses IA, IB, and IC, all share the fundamental mechanism of binding to and blocking voltage-gated sodium channels in myocardial cells. This action slows the rapid depolarization phase (phase 0) of the cardiac action potential, thereby decreasing conduction velocity and increasing the effective refractory period, which helps to terminate or prevent re-entrant arrhythmias.
A: Potassium channel blocking
Potassium channel blocking is the primary mechanism of Class III antiarrhythmic drugs (e.g., amiodarone, sotalol, dofetilide). This action prolongs repolarization and the effective refractory period, which is distinct from the sodium channel blockade characteristic of Class I agents.
B: Calcium channel blocking
Calcium channel blocking is the mechanism of Class IV antiarrhythmic drugs (e.g., verapamil, diltiazem). These drugs primarily affect nodal tissues, slowing conduction through the AV node and decreasing heart rate, which is not the common action of Class I antiarrhythmics.
D: Beta adrenoceptor blocking
Beta adrenoceptor blocking is the mechanism of Class II antiarrhythmic drugs (e.g., propranolol, metoprolol). These drugs reduce sympathetic stimulation to the heart, decreasing heart rate, contractility, and conduction velocity, particularly through the AV node, which differs from Class I drug action.
Class I antiarrhythmic drugs, encompassing subclasses IA, IB, and IC, all share the fundamental mechanism of binding to and blocking voltage-gated sodium channels in myocardial cells. This action slows the rapid depolarization phase (phase 0) of the cardiac action potential, thereby decreasing conduction velocity and increasing the effective refractory period, which helps to terminate or prevent re-entrant arrhythmias.
A: Potassium channel blocking
Potassium channel blocking is the primary mechanism of Class III antiarrhythmic drugs (e.g., amiodarone, sotalol, dofetilide). This action prolongs repolarization and the effective refractory period, which is distinct from the sodium channel blockade characteristic of Class I agents.
B: Calcium channel blocking
Calcium channel blocking is the mechanism of Class IV antiarrhythmic drugs (e.g., verapamil, diltiazem). These drugs primarily affect nodal tissues, slowing conduction through the AV node and decreasing heart rate, which is not the common action of Class I antiarrhythmics.
D: Beta adrenoceptor blocking
Beta adrenoceptor blocking is the mechanism of Class II antiarrhythmic drugs (e.g., propranolol, metoprolol). These drugs reduce sympathetic stimulation to the heart, decreasing heart rate, contractility, and conduction velocity, particularly through the AV node, which differs from Class I drug action.